Literature DB >> 26420977

Corticosteroid and nucleoside analogue for hepatitis B virus-related acute liver failure.

Keiichi Fujiwara1, Shin Yasui1, Osamu Yokosuka1.   

Abstract

The early introduction of combination therapy of high-dose corticosteroid and nucleoside analogue is beneficial for the rescue of severe acute exacerbation of chronic hepatitis B.

Entities:  

Keywords:  Acute liver failure; Chronic hepatitis B; Corticosteroid; Exacerbation; Nucleoside analogue

Mesh：

Substances：

Year:  2015        PMID： 26420977      PMCID： PMC4579897          DOI： 10.3748/wjg.v21.i36.10485

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  7 in total

1.  Treatment of HBV reactivation after withdrawal of immunosuppression.

Authors:  J Y Lau; G L Bird; A E Gimson; G J Alexander; R Williams
Journal:  Lancet       Date:  1991-03-30       Impact factor: 79.321

2.  Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B.

Authors:  Keiichi Fujiwara; Shin Yasui; Yutaka Yonemitsu; Kenichi Fukai; Makoto Arai; Fumio Imazeki; Akihiro Suzuki; Hiroshi Suzuki; Tomohito Sadahiro; Shigeto Oda; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

3.  Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis B.

Authors:  S Yasui; K Fujiwara; M Nakamura; T Miyamura; Y Yonemitsu; R Mikata; M Arai; T Kanda; F Imazeki; S Oda; O Yokosuka
Journal:  J Viral Hepat       Date:  2014-04-21       Impact factor: 3.728

4.  The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B.

Authors:  Keiichi Fujiwara; Shin Yasui; Koichiro Okitsu; Yutaka Yonemitsu; Shigeto Oda; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2010-07-09       Impact factor: 7.527

5.  Combined glucocorticoid and antiviral therapy of hepatitis B virus-related liver failure.

Authors:  Jan-Hendrik Bockmann; Maura Dandri; Stefan Lüth; Nadine Pannicke; Ansgar W Lohse
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

6.  Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B.

Authors:  Keiichi Fujiwara; Osamu Yokosuka; Hiroshige Kojima; Tatsuo Kanda; Hiromitsu Saisho; Hiroyuki Hirasawa; Hiroshi Suzuki
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

7.  Efficacy of high-dose corticosteroid in the early stage of viral acute liver failure.

Authors:  Keiichi Fujiwara; Shin Yasui; Yutaka Yonemitsu; Rintaro Mikata; Makoto Arai; Tatsuo Kanda; Fumio Imazeki; Shigeto Oda; Osamu Yokosuka
Journal:  Hepatol Res       Date:  2013-05-22       Impact factor: 4.288
  7 in total
  1 in total

1.  The "Traditional Chinese medicine regulating liver regeneration" treatment plan for reducing mortality of patients with hepatitis B-related liver failure based on real-world clinical data.

Authors:  Ling Dai; Xiang Gao; Zhihua Ye; Hanmin Li; Xin Yao; Dingbo Lu; Na Wu
Journal:  Front Med       Date:  2021-01-12       Impact factor: 4.592
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.